Georgetown University Law Center Scholarship @ GEORGETOWN LAW 2014 Pandemic Disease, Biological Weapons, and War Laura K. Donohue Georgetown University Law Center,
[email protected] This paper can be downloaded free of charge from: https://scholarship.law.georgetown.edu/facpub/1296 http://ssrn.com/abstract=2350304 Laura K. Donohue, Pandemic Disease, Biological Weapons, and War in LAW AND WAR: (Sarat, Austin, Douglas, Lawrence, and Umphrey, Martha Merrill, eds., Stanford University Press, 2014) This open-access article is brought to you by the Georgetown Law Library. Posted with permission of the author. Follow this and additional works at: https://scholarship.law.georgetown.edu/facpub Part of the Defense and Security Studies Commons, Military and Veterans Studies Commons, Military, War, and Peace Commons, and the National Security Law Commons PANDEMIC DISEASE , BIOLOGICAL WEAPONS , AND WAR Laura K. Donohue * Over the past two decades, concern about the threat posed by biological weapons has grown. Biowarfare is not new. 1 But prior to the recent trend, the threat largely centered on state use of such weapons. 2 What changed with the end of the Cold War was the growing apprehension that materials and knowledge would proliferate beyond industrialized states’ control, and that “rogue states” or nonstate actors would acquire and use biological weapons. 3 Accordingly, in 1993 senators Samuel Nunn, Richard Lugar, and Pete Dominici expanded the Cooperative Threat Reduction Program to assist the former Soviet republics in securing biological agents and weapons knowledge. The Defense Against Weapons of Mass Destruction Act gave the Pentagon lead agency responsibility. 4 Senator Lugar explained, “[B]iological weapons, materials, and know-how are now more available to terrorists and rogue nations than at any other time in our history.”5 The United States was not equipped to manage the crisis.